Celcuity Inc. CELC
Nasdaq · XNAS · stock · Services-Medical Laboratories · website · IPO 2017-09-20
Celcuity Inc. statistics & valuation
Market cap$4.9B
P / B48.5×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -37.9% | -45.6% | -33.4% | -23.0% | -34.5% |
| Return on equity | -176.1% | -96.7% | -45.6% | -30.2% | -43.1% |
| Debt / equity | 1.37× | 0.91× | 0.27× | 0.27× | 0.23× |
| Current ratio | 10.55 | 7.71 | 13.43 | 25.46 | 34.06 |
Source: SEC EDGAR filings · CIK 0001603454 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.